GET THE APP

Announcement of 2nd International Conference on Orphan Drugs | 53944

International Journal of Applied Biology and Pharmaceutical Technology

Abstract

Announcement of 2nd International Conference on Orphan Drugs & Rare Diseases

Alireza Heidari

2nd International Conference on Orphan Drugs &Rare Diseases invites all the global doctors andresearchers to share their research at this exclusivescientific program held in Dubai, UAE during March 22-23, 2021 which based on the theme “Explore the Recent advancements in Rare Diseases Research. Scientific sessions of Orphan Drugs 2021 includes Clinical Case Studies on Rare Diseases, Immunological Rare Diseases, Rare Diseases in Neurology, Rare Gynecological and Obstetrical Diseases, Orphan Drugs Potentiality. Dubai is leading city of United Arab Emirates, as well as famous city in the world. The destinations which make Dubai special are Burj Khalifa, Burj Al Arab Jumeirah Beach, Dubai Palm Beach, Jumeirah Mosque, Dubai Creek, Dubai Mall, Dubai Museum, Dubai Aquarium. An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases. The assignment of orphan status to a disease and to drugs developed to treat it is a matter of public policy in many countries and has yielded medical breakthroughs that might not otherwise have been achieved, due to the economics of drug research and development. There are greater than 6000 Rare Diseases. Many rare diseases are identified at the age of childhood, making diagnostic awareness and understanding on treatment and care specifically necessary for pediatricians. The Rare Diseases are so rare that rarity can lead to various troubles including: difficulties in obtaining timely,correct diagnoses; lack of experienced healthcare supervisors; useful, dependable and well timed statistics may additionally be challenging to retrieve; lookup things to do are very less; growing new prescribed drugs can also not be economically feasible; treatments are on occasion very expensive; and in developing countries, the issues are compounded via different resource limitations. Orphan Drug 2020 is emerging up with an exciting and excessive knowledge gaining convention application this yr also which includes plenary lectures, symposia, workshops on a range of topics, poster shows and a number packages for contributors from at some stage in the world. We welcome you to join us at the International Conference on Orphan Drugs and Rare Diseases in Berlin the place you will be sure
to have a significant ride with scholars from around the world. The Rare Diseases Conference aims to extend the reach, impact and trade of scholarly thoughts via revolutionary technology, determined commitment and awesome service. It objectives to provide international collaboration and trade of complete and ultra-modern data on basic, translational, and utilized medical research on Rare iseases and Orphan Drugs. The field of rare disease products is continuously growing, expecting to reach $180 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market.Announcement of 2nd International Conference on Orphan Drugs & Rare Diseases Alireza Heidari California South University, USA 2020
 

Top